# Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis

> **NCT00355095** · PHASE2 · COMPLETED · sponsor: **Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH** · enrollment: 40 (actual)

## Conditions studied

- Optic Neuritis

## Interventions

- **DRUG:** Erythropoietin

## Key facts

- **NCT ID:** NCT00355095
- **Lead sponsor:** Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2011-02
- **Final completion:** 2011-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00355095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00355095, "Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00355095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*